| Product Code: ETC9396948 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Antimicrobial Resistance Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Antimicrobial Resistance Market - Industry Life Cycle |
3.4 South Korea Antimicrobial Resistance Market - Porter's Five Forces |
3.5 South Korea Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 South Korea Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 South Korea Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 South Korea Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 South Korea Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in South Korea |
4.2.2 Rising awareness about the importance of antimicrobial stewardship |
4.2.3 Technological advancements in antimicrobial resistance diagnostics and treatment |
4.3 Market Restraints |
4.3.1 Lack of standardized guidelines for antimicrobial usage |
4.3.2 High cost associated with antimicrobial resistance treatments |
4.3.3 Increasing regulatory challenges in the development and approval of new antimicrobial agents |
5 South Korea Antimicrobial Resistance Market Trends |
6 South Korea Antimicrobial Resistance Market, By Types |
6.1 South Korea Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 South Korea Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 South Korea Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 South Korea Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 South Korea Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 South Korea Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 South Korea Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 South Korea Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 South Korea Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 South Korea Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 South Korea Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 South Korea Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 South Korea Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 South Korea Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 South Korea Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 South Korea Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 South Korea Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 South Korea Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 South Korea Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 South Korea Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 South Korea Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 South Korea Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 South Korea Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 South Korea Antimicrobial Resistance Market Export to Major Countries |
7.2 South Korea Antimicrobial Resistance Market Imports from Major Countries |
8 South Korea Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.2 Number of new antimicrobial resistance diagnostic technologies introduced in the market |
8.3 Rate of adherence to antimicrobial prescribing guidelines by healthcare professionals |
9 South Korea Antimicrobial Resistance Market - Opportunity Assessment |
9.1 South Korea Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 South Korea Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 South Korea Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 South Korea Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 South Korea Antimicrobial Resistance Market - Competitive Landscape |
10.1 South Korea Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 South Korea Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here